HEPLA Trademark

Trademark Overview


On Tuesday, March 2, 2021, a trademark application was filed for HEPLA with the United States Patent and Trademark Office. The USPTO has given the HEPLA trademark a serial number of 90554423. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 13, 2023. This trademark is owned by Hepla Sciences, Inc.. The HEPLA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

vaccines; anxiolytics; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

Pharmaceutical research and development; Development of pharmaceutical preparations and drugs; Medical and scientific research for others in the fields of pharmaceuticals, biotherapeutics, cellular therapy, gene therapy and immunotherapy; Development of pharmaceutical preparations and drugs for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, viral and infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; Provision of scientific research information in the field of pharmaceuticals and clinical trials
hepla

General Information


Serial Number90554423
Word MarkHEPLA
Filing DateTuesday, March 2, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2022

Trademark Statements


Goods and Servicesvaccines; anxiolytics; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Goods and ServicesPharmaceutical research and development; Development of pharmaceutical preparations and drugs; Medical and scientific research for others in the fields of pharmaceuticals, biotherapeutics, cellular therapy, gene therapy and immunotherapy; Development of pharmaceutical preparations and drugs for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, viral and infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; Provision of scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHepla Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameHepla Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events


Event DateEvent Description
Monday, February 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 17, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2022PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 13, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 13, 2022ASSIGNED TO LIE
Monday, April 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 11, 2022EXAMINER'S AMENDMENT ENTERED
Monday, April 11, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 11, 2022EXAMINERS AMENDMENT E-MAILED
Monday, April 11, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 28, 2021NON-FINAL ACTION E-MAILED
Tuesday, September 28, 2021NON-FINAL ACTION WRITTEN
Friday, September 24, 2021ASSIGNED TO EXAMINER
Tuesday, June 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 5, 2021NEW APPLICATION ENTERED